Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding and preventing type 1 diabetes through the unique working model of TrialNet
Manuela Battaglia, Mark S. Anderson, Jane H. Buckner, et al.
Diabetologia (2017) Vol. 60, Iss. 11, pp. 2139-2147
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
Peter J. Thompson, Ajit Shah, Vasilis Ntranos, et al.
Cell Metabolism (2019) Vol. 29, Iss. 5, pp. 1045-1060.e10
Open Access | Times Cited: 284
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia, Simi Ahmed, Mark S. Anderson, et al.
Diabetes Care (2019) Vol. 43, Iss. 1, pp. 5-12
Open Access | Times Cited: 280
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
Emily K. Sims, Brian N. Bundy, Kenneth Stier, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 583
Open Access | Times Cited: 233
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective
Emily K. Sims, Rachel Besser, Colin Dayan, et al.
Diabetes (2022) Vol. 71, Iss. 4, pp. 610-623
Open Access | Times Cited: 130
ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents
Jennifer Couper, Michael J. Haller, Carla J. Greenbaum, et al.
Pediatric Diabetes (2018) Vol. 19, pp. 20-27
Closed Access | Times Cited: 122
Type 1 diabetes mellitus: much progress, many opportunities
Alvin C. Powers
Journal of Clinical Investigation (2021) Vol. 131, Iss. 8
Open Access | Times Cited: 100
Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes
Martha Campbell‐Thompson, Stephanie L. Filipp, Joseph R. Grajo, et al.
Diabetes Care (2018) Vol. 42, Iss. 2, pp. 281-287
Open Access | Times Cited: 92
β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis
Carmella Evans‐Molina, Emily K. Sims, Linda A. DiMeglio, et al.
JCI Insight (2018) Vol. 3, Iss. 15
Open Access | Times Cited: 85
Utility of genetic risk scores in type 1 diabetes
Amber M Luckett, Michael N. Weedon, Gareth Hawkes, et al.
Diabetologia (2023) Vol. 66, Iss. 9, pp. 1589-1600
Open Access | Times Cited: 29
IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes
Emily K. Sims, David Cuthbertson, Lauric A. Ferrat, et al.
Diabetologia (2025)
Open Access | Times Cited: 1
Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes
Polly J. Bingley, Diane K. Wherrett, Ann Shultz, et al.
Diabetes Care (2018) Vol. 41, Iss. 4, pp. 653-661
Open Access | Times Cited: 71
Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling
Daniel J. Perry, Clive Wasserfall, Richard A. Oram, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 70
DPVis: Visual Analytics With Hidden Markov Models for Disease Progression Pathways
Bum Chul Kwon, Vibha Anand, Kristen Severson, et al.
IEEE Transactions on Visualization and Computer Graphics (2020) Vol. 27, Iss. 9, pp. 3685-3700
Open Access | Times Cited: 60
The role of beta-cell dysfunction in early type 1 diabetes
Emily K. Sims, Raghavendra G. Mirmira, Carmella Evans‐Molina
Current Opinion in Endocrinology Diabetes and Obesity (2020) Vol. 27, Iss. 4, pp. 215-224
Open Access | Times Cited: 56
Exogenous spermine attenuates rat diabetic cardiomyopathy via suppressing ROS-p53 mediated downregulation of calcium-sensitive receptor
Yuehong Wang, Junting Chen, Siwei Li, et al.
Redox Biology (2020) Vol. 32, pp. 101514-101514
Open Access | Times Cited: 53
Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
A. R. Lind, Eva Freyhult, Felipe de Jesus Cortez, et al.
EBioMedicine (2024) Vol. 104, pp. 105144-105144
Open Access | Times Cited: 6
Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children
Alexandra Paun, Christopher Yau, Shahab Meshkibaf, et al.
Science Immunology (2019) Vol. 4, Iss. 32
Open Access | Times Cited: 54
Harmonization of immunoassays for biomarkers in diabetes mellitus
Sebastian Hörber, Peter Achenbach, Erwin Schleicher, et al.
Biotechnology Advances (2019) Vol. 39, pp. 107359-107359
Open Access | Times Cited: 52
Cell type–specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes
Matthew J. Dufort, Carla J. Greenbaum, Cate Speake, et al.
JCI Insight (2019) Vol. 4, Iss. 4
Open Access | Times Cited: 46
It is time for a moonshot to find “Cures” for diabetic retinal disease
S. Robert Levine, Przemysław Sapieha, Sanjoy Dutta, et al.
Progress in Retinal and Eye Research (2022) Vol. 90, pp. 101051-101051
Closed Access | Times Cited: 25
Current Management of Glycemia in Children with Type 1 Diabetes Mellitus
Mark A. Sperling, Lori M. Laffel
New England Journal of Medicine (2022) Vol. 386, Iss. 12, pp. 1155-1164
Closed Access | Times Cited: 25
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes
David B. Dunger, Sylvaine F. A. Bruggraber, Adrian Mander, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study
Mohamed Ghalwash, Vibha Anand, Olivia Lou, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 4, pp. 261-268
Open Access | Times Cited: 16
Human immune phenotyping reveals accelerated aging in type 1 diabetes
Melanie R. Shapiro, Xiaoru Dong, Daniel J. Perry, et al.
JCI Insight (2023) Vol. 8, Iss. 17
Open Access | Times Cited: 16
The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms
Pia Leete, Roberto Mallone, Sarah J. Richardson, et al.
Current Diabetes Reports (2018) Vol. 18, Iss. 11
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top